Notify your GLP-1 prescriber before starting tirzepatide
Consider the benefits of a personalized telehealth program over the standard retail pharmacy experience
Before starting any GLP-1 medication, talk to a licensed healthcare provider about your personal or family history of medullary thyroid carcinoma, MEN 2, pancreatitis, gallbladder disease, severe gastrointestinal disease, pregnancy, breastfeeding, current medications, allergies, and any prior adverse reactions
Semaglutide targets GLP-1 only, while tirzepatide targets both GLP-1 and GIP
These can include nausea, vomiting, stomach problems, diarrhea, and loss of appetite
this is Trimi's own intake threshold, not a guarantee that treatment is appropriate